A method for detecting residual solvent in iodofol
By using headspace gas chromatography with an ultra-inert gas chromatographic column and specific parameters, the complexity of detecting multiple residual solvents in iodofol has been solved, achieving efficient and accurate detection results, which is suitable for the quality control of iodofol.
Patent Information
- Application Number
- CN202510470294.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-04-15
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2045-04-15
AI Technical Summary
Existing methods for detecting iodofol are complex to operate and inefficient, making it difficult to sensitively and accurately detect the content of various residual solvents.
Headspace gas chromatography, using an ultra-inert gas chromatographic column and specific detection parameters, including cyanopropyl-phenyl-polydimethylsiloxane packing material, split injection and programmed temperature rise, combined with a flame ionization detector, enables efficient detection of ethanol, acetic acid, N,N-dimethylacetamide, benzene and chloroform in iodofol.
It enables convenient, efficient, and accurate detection of residual solvents in iodofol, meeting the requirements of drug quality control, and possessing good specificity and sensitivity.
Smart Images

Figure CN120084916B_ABST
Abstract
Description
Technical Field
[0001] This disclosure belongs to the field of pharmaceutical analysis technology, specifically relating to a method for detecting residual solvents in iodofol. Background Technology
[0002] Ioversol is a widely used second-generation nonionic iodine contrast agent in clinical practice. It boasts advantages such as low toxicity, high water solubility, low viscosity, low osmotic pressure, low incidence of adverse reactions, and relatively low price, making it widely used in medical imaging. Solvents used in the production process, such as ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform, may remain in the final product, affecting its purity and safety. Controlling residual solvents is crucial to ensuring drug quality. Traditional detection methods often employ solvent extraction, which are complex and inefficient. Therefore, a sensitive, accurate, and easy-to-use detection method is urgently needed to monitor the content of these residual solvents. Summary of the Invention
[0003] This disclosure establishes a highly efficient headspace gas chromatography method by optimizing gas chromatography detection parameters. This method can rapidly and accurately detect multiple residual solvents in iodofol active pharmaceutical ingredient, including ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform. The method exhibits high specificity, high sensitivity, and a wide linear range, meeting the requirements for drug quality control.
[0004] In a first aspect, this disclosure provides a method for detecting residual solvents in iodofol, which uses headspace gas chromatography (HSGC) for determination, wherein the residual solvent is selected from one or more of ethanol, acetic acid, N,N-dimethylacetamide, benzene and chloroform;
[0005] The conditions for the headspace gas chromatography method are as follows:
[0006] The chromatographic column is an ultra-inert gas chromatographic column, and its packing material is cyanopropyl-phenyl-polydimethylsiloxane;
[0007] The headspace equilibrium temperature is 90–110℃ (e.g., 90℃, 95℃, 100℃, 105℃ or 110℃), and the headspace equilibrium time is 20–40 min (e.g., 20 min, 25 min, 30 min, 35 min or 40 min).
[0008] The injection mode is split injection, with a split ratio of 1:1.
[0009] In some embodiments, in the first aspect, the residual solvent is ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform.
[0010] Secondly, this disclosure provides a method for determining at least two residual solvents in iodofol, which employs headspace gas chromatography. The residual solvents are selected from ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform. The headspace gas chromatography conditions are as follows:
[0011] The chromatographic column is an ultra-inert gas chromatographic column, and its packing material is cyanopropyl-phenyl-polydimethylsiloxane;
[0012] The headspace equilibrium temperature is 90–110℃ (e.g., 90℃, 95℃, 100℃, 105℃ or 110℃), and the headspace equilibrium time is 20–40 min (e.g., 20 min, 25 min, 30 min, 35 min or 40 min).
[0013] The injection mode is split injection, with a split ratio of 1:1.
[0014] In some embodiments, in the first and / or second aspects, the packing material of the ultra-inert gas chromatographic column is 6% cyanopropyl / phenyl and 94% polydimethylsiloxane.
[0015] In some implementations, in the first and / or second aspects, the ultra-inert gas chromatographic column is a DB624UI column.
[0016] In some embodiments, in the first and / or second aspects, the chromatographic column of the headspace gas chromatography has a specification of 60m × 0.32mm × 1.8μm.
[0017] In some embodiments, in the first and / or second aspects, the carrier gas used in the headspace gas chromatography is nitrogen or helium.
[0018] In some embodiments, in the first and / or second aspects, the carrier gas used in the headspace gas chromatography is nitrogen.
[0019] In some embodiments, in the first and / or second aspects, the flow rate of the carrier gas used in the headspace gas chromatography is 2 to 4 mL / min, for example 2 mL / min, 2.5 mL / min, 3 mL / min, 3.5 mL / min or 4 mL / min.
[0020] In some embodiments, in the first and / or second aspects, the flow rate of the carrier gas used in the headspace gas chromatography is 3 mL / min.
[0021] In some embodiments, in the first and / or second aspects, the column temperature of the headspace gas chromatography is programmed, with an initial temperature of 36–44°C (e.g., 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C, or 44°C), increased to 190–210°C (e.g., 190°C, 195°C, 200°C, 205°C, or 210°C) at a rate of 15–25°C / min (e.g., 15°C / min, 16°C / min, 17°C / min, 18°C / min, 19°C / min, 20°C / min, 21°C / min, 22°C / min, 23°C / min, 24°C / min, or 25°C / min), and held for 5–15 min (e.g., 5 min, 6 min, 7 min, 8 min, 9 min, 10 min, 11 min, 12 min, 13 min, 14 min, or 15 min).
[0022] In some embodiments, in the first and / or second aspects, the headspace gas chromatography column temperature is programmed, starting at 40°C, increasing to 200°C at a rate of 20°C / min, and holding for 10min.
[0023] In some embodiments, in the first and / or second aspects, the headspace equilibrium temperature of the headspace gas chromatography is 100°C and the headspace equilibrium time is 30 min.
[0024] In some embodiments, in the first and / or second aspects, the injection port temperature of the headspace gas chromatography is 210–240°C, for example 210°C, 215°C, 220°C, 225°C, 230°C, 235°C, or 240°C.
[0025] In some embodiments, in the first and / or second aspects, the injection port temperature of the headspace gas chromatography is 220–235°C.
[0026] In some embodiments, in the first and / or second aspects, the injection port temperature of the headspace gas chromatography is 220°C.
[0027] In some embodiments, in the first and / or second aspects, the detector for the headspace gas chromatography is a flame ionization detector (FID).
[0028] In some embodiments, in the first and / or second aspects, the temperature of the detector for the headspace gas chromatography is 240–260°C, for example 240°C, 245°C, 250°C, 255°C, or 260°C.
[0029] In some embodiments, in the first and / or second aspects, the temperature of the detector for the headspace gas chromatography is 250°C.
[0030] In some embodiments, in the first and / or second aspects, the injection volume of the headspace gas chromatography is 0.1 to 3 μL, for example 0.5 μL, 1 μL, 1.5 μL, 2 μL, 2.5 μL or 3 μL.
[0031] In some embodiments, in the first and / or second aspects, the injection volume of the headspace gas chromatography is 1 μL.
[0032] In some embodiments, in the first and / or second aspects, the headspace gas chromatography run time is 45 to 60 min, for example 45 min, 46 min, 47 min, 48 min, 49 min, 50 min, 51 min, 52 min, 53 min, 54 min, 55 min, 56 min, 57 min, 58 min, 59 min, or 60 min.
[0033] In some implementations, in the first and / or second aspects, the headspace gas chromatography run time is 52 min.
[0034] In some implementations, in the first and / or second aspects, the detection method includes the following steps:
[0035] (1) Prepare a reference solution containing the aforementioned residual solvent;
[0036] (2) Prepare the test solution of iodofol;
[0037] (3) Headspace gas chromatography was used to detect the reference solution and the test solution respectively.
[0038] In some embodiments, step (1) involves preparing the reference solution containing residual solvent by mixing a diluent and the residual solvent to obtain a reference stock solution, and then diluting the reference stock solution by 5 to 200 times (e.g., 5 times, 10 times, 15 times, 20 times, 25 times, 30 times, 35 times, 40 times, 45 times, 50 times, 55 times, 60 times, 65 times, 70 times, 75 times, 80 times, 85 times, 90 times, 95 times, 100 times, 150 times, or 200 times) to obtain the reference solution, wherein the diluent is water (e.g., purified water).
[0039] In some embodiments, step (2) involves preparing the test solution of iodofol by mixing iodofol with a diluent to obtain the test solution, wherein the diluent is water (e.g., purified water).
[0040] In some embodiments, in step (2), the test solution contains a residual solvent selected from one or more of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform.
[0041] In some embodiments, in step (2), the test solution contains the aforementioned residual solvent, and the preparation method of the iodofol test solution includes: mixing iodofol and the reference solution in step (1) to obtain the test solution.
[0042] In some implementations, in step (2), the diluent used in the preparation of the test solution is water, such as purified water.
[0043] In some embodiments, in the first and / or second aspects, the resolution of one or more peaks of ethanol, chloroform, acetic acid, benzene and N,N-dimethylacetamide detected by the detection method is greater than 1.5, for example greater than 2 or greater than 2.5.
[0044] In some embodiments, in the first and / or second aspects, the peak area RSD of one or more peaks of ethanol, chloroform, acetic acid, benzene, and N,N-dimethylacetamide detected by the detection method is less than or equal to 10%, for example, less than or equal to 9.5%, less than or equal to 9%, less than or equal to 8.5%, less than or equal to 8%, less than or equal to 7.5%, less than or equal to 7%, less than or equal to 6.5%, or less than or equal to 6%.
[0045] In some embodiments, in the first and / or second aspects, the S / N ratio of one or more peaks of ethanol, chloroform, acetic acid, benzene, and N,N-dimethylacetamide detected by the detection method is greater than 3.
[0046] In some embodiments, in the first and / or second aspects, the S / N ratio of one or more peaks of ethanol, chloroform, acetic acid, benzene, and N,N-dimethylacetamide detected by the detection method is greater than 10.
[0047] In some embodiments, in the first and / or second aspects, the retention time RSD of one or more peaks of ethanol, chloroform, acetic acid, benzene and N,N-dimethylacetamide detected by the detection method is less than or equal to 2.0%, for example less than or equal to 1.5%, less than or equal to 1.0%, or less than or equal to 0.5%.
[0048] The method for detecting residual solvents in iodofol disclosed herein employs headspace gas chromatography, which can simultaneously detect the contents of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform. This method is convenient, efficient, and accurate, and conforms to the guidelines for method validation in the Chinese Pharmacopoeia in terms of system suitability, limit of quantitation, linearity, precision, accuracy, and solution stability. It can be used for the quality control of iodofol raw material.
[0049] Terminology Definition
[0050] To facilitate understanding of this disclosure, certain technical and scientific terms are specifically defined below. Unless otherwise expressly defined herein, all other technical and scientific terms used herein have the meanings commonly understood by one of ordinary skill in the art to which this disclosure pertains.
[0051] Unless the context clearly requires otherwise, throughout the specification and claims, the words “comprising,” “having,” “including,” etc., should be understood as having an inclusive meaning, rather than an exclusive or exhaustive meaning; that is, the meaning of “including but not limited to.”
[0052] The numerical values disclosed herein have a certain degree of error; generally, ±10% is within a reasonable error range. Of course, the context in which the value is used must be considered. For example, in the case of particle size of the active ingredient, where the error variation after measurement does not exceed ±10%, the value can be ±9%, ±8%, ±7%, ±6%, ±5%, ±4%, ±3%, ±2%, or ±1%, preferably ±5%.
[0053] In this disclosure, "one or more" means one, two or more.
[0054] In this disclosure, "one or more" means one, two or more items.
[0055] In this disclosure, "one or more" means one, two or more. Attached Figure Description
[0056] Figure 1 This is the gas chromatogram of the blank solution.
[0057] Figure 2 This is a gas chromatogram of the system suitability solution.
[0058] Figure 3 This is the gas chromatogram of the test solution.
[0059] Figure 4 The gas chromatogram of the spiked test sample 1 solution (ethanol, acetic acid, N,N-dimethylacetamide, benzene).
[0060] Figure 5The gas chromatogram of the spiked test sample 2 solution (chloroform).
[0061] Figure 6 The image shows the gas chromatogram of reference solution 1 (ethanol, acetic acid, N,N-dimethylacetamide, benzene).
[0062] Figure 7 This is the gas chromatogram of reference solution 2 (chloroform).
[0063] Figure 8 This is a linear regression plot of ethanol.
[0064] Figure 9 This is a linear regression plot for acetic acid.
[0065] Figure 10 The graph shows the linear regression of N,N-dimethylacetamide.
[0066] Figure 11 This is a linear regression plot for benzene.
[0067] Figure 12 This is a linear regression plot for chloroform. Detailed Implementation
[0068] The present disclosure is further described below with reference to embodiments, but these embodiments are not intended to limit the scope of the present disclosure.
[0069] Example 1:
[0070] 1. Instruments and reagents
[0071] Shimadzu GC-2014HS10, purified water (Wahaha), ethanol (HPLC grade, MackLin, 99.8%), glacial acetic acid (GC grade, MackLin, 99.8%), N,N-dimethylacetamide (HPLC grade, MackLin, 99.8%), chloroform (analytical grade, Sinopharm Chemical Reagent Co., Ltd., 99%), benzene (analytical grade, Sinopharm Chemical Reagent Co., Ltd.)
[0072] 2. Solution preparation
[0073] Blank solution (diluent): purified water
[0074] Preparation of reference stock solutions: Accurately weigh approximately 260 mg of ethanol reference standard, approximately 260 mg of acetic acid reference standard, approximately 58 mg of N,N-dimethylacetamide reference standard, approximately 20 mg of benzene reference standard, and approximately 32 mg of chloroform reference standard. Place each in a 100 mL volumetric flask, dissolve and dilute to the mark with diluent, and mix well to obtain reference stock solutions with ethanol concentration of approximately 2600.0000 μg / mL, acetic acid concentration of approximately 2600.0000 μg / mL, N,N-dimethylacetamide concentration of approximately 580.0000 μg / mL, benzene concentration of approximately 200.0000 μg / mL, and chloroform concentration of approximately 320.0000 μg / mL.
[0075] Preparation of Reference Solution 1: Accurately transfer 5 mL of ethanol stock solution, 5 mL of acetic acid stock solution, 5 mL of N,N-dimethylacetamide stock solution, and 0.5 mL of benzene stock solution to a 50 mL amber volumetric flask. Dilute to the mark with diluent and mix well. Accurately measure 2.0 mL of the above solution into a 20 mL headspace vial, seal, and prepare Reference Solution 1 with an ethanol concentration of approximately 260.0000 μg / mL, an acetic acid concentration of approximately 260.0000 μg / mL, an N,N-dimethylacetamide concentration of approximately 58.0000 μg / mL, and a benzene concentration of approximately 2.0000 μg / mL.
[0076] Preparation of reference solution 2: Accurately transfer 1 mL of chloroform reference stock solution into a 100 mL brown volumetric flask, dilute to the mark with diluent, and shake well. Accurately measure 2.0 mL of the above solution into a 20 mL headspace vial, seal, and prepare reference solution 2 with a chloroform concentration of approximately 3.2000 μg / mL.
[0077] Test solution: Accurately weigh 2.0 g of iodofol raw material and accurately measure 2.0 mL of purified water. Place them in a 20 mL headspace vial, seal, and prepare a test solution of iodofol with a concentration of approximately 1000 mg / mL.
[0078] Preparation of spiked test solution 1: Accurately weigh approximately 2.0 g of iodofol raw material and place it in a 20 mL headspace vial. Accurately transfer 2.0 mL of reference solution 1, seal, and prepare spiked test solution 1 with an ethanol concentration of approximately 260.0000 μg / mL, an acetic acid concentration of approximately 260.0000 μg / mL, an N,N-dimethylacetamide concentration of approximately 58.0000 μg / mL, a benzene concentration of approximately 2.0000 μg / mL, and an iodofol concentration of approximately 1000 mg / mL.
[0079] Preparation of spiked test solution 2: Weigh approximately 2.0 g of iodofol raw material accurately and place it in a 20 mL headspace vial. Accurately transfer 2.0 mL of reference solution 2, seal, and prepare spiked test solution 2 with a chloroform concentration of approximately 3.2000 μg / mL and an iodofol concentration of approximately 1000 mg / mL.
[0080] Preparation of system suitability solutions: Accurately transfer 5 mL of ethanol reference stock solution, 5 mL of acetic acid reference stock solution, 5 mL of N,N-dimethylacetamide reference stock solution, 0.5 mL of benzene reference stock solution, and 0.5 mL of chloroform reference stock solution into a 50 mL amber volumetric flask. Dilute to the mark with diluent and mix well. Accurately measure 2.0 mL of the above solution into a 20 mL headspace vial and seal. This yields system suitability solutions with an ethanol concentration of approximately 260.0000 μg / mL, an acetic acid concentration of approximately 260.0000 μg / mL, an N,N-dimethylacetamide concentration of approximately 58.0000 μg / mL, a benzene concentration of approximately 2.0000 μg / mL, and a chloroform concentration of approximately 3.2000 μg / mL.
[0081] 2. The chromatographic conditions for gas chromatography are as follows:
[0082] Column: DB624UI, 60m × 0.32mm × 1.8μm; Detector: FID; Flow rate: 3mL / min; Split ratio: 1:1; Injection volume: 1μL; Run time: 52min; Column temperature: programmed temperature rise (40℃; ramp to 200℃ at 20℃ / min, hold for 10min); Injector temperature: 220℃; Detector temperature: 250℃; Equilibrium temperature: 100℃; Equilibrium time: 30min; Transfer line temperature: 110℃.
[0083] The gas chromatogram of the blank solution is as follows: Figure 1 As shown, the blank solution does not interfere with the determination of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform. The gas chromatogram of the system suitability solution is shown below. Figure 2 As shown, the resolution of ethanol (retention time 5.819 min), acetic acid (retention time 7.817 min), N,N-dimethylacetamide (retention time 11.914 min), benzene (retention time 8.099 min), and chloroform (retention time 7.595 min) from surrounding peaks (the other peaks closest to the residual solvent peak) is greater than 1.5. The gas chromatogram of the test solution is shown below. Figure 3 As shown, the resolution between ethanol and the surrounding peaks is 2.929, which is greater than 1.5. The gas chromatograms of spiked sample 1 and spiked sample 2 are shown below. Figure 4 and Figure 5As shown, the resolutions of the peaks for ethanol, chloroform, acetic acid, benzene, and N,N-dimethylacetamide from the surrounding peaks (the other peaks closest to the residual solvent peak) were 2.916, 10.560, 14.607, 3.704, and 46.322, respectively, all greater than 1.5. This method exhibits good specificity.
[0084] Comparative Example 1:
[0085] Different chromatographic columns (DB-WAX UI, CP-Volamine, and DB-624UI) were used for analysis. Gas chromatography was employed to detect the reference solution 1 prepared in Example 1. Except for the column type, the specific gas chromatography conditions were the same as in Example 1. The resolution of each solvent peak was recorded.
[0086] The results showed that when the column was DB-WAX UI, the resolution of the residual solvent ethanol peak was only 1.0, and the peak exhibited tailing. When the column was CP-Volamine, the resolution of the residual solvent ethanol peak was 1.1. According to relevant drug quality standards, the resolution of the residual solvent peak must be greater than 1.5, which clearly does not meet the current standard. When the column was DB-624UI, the resolution of the residual solvent ethanol peak was 2.916, which meets the requirements.
[0087] Comparative Example 2:
[0088] The reference solution 1 prepared in Example 1 was detected by gas chromatography. Except for the different headspace equilibrium temperature, the specific gas chromatography conditions were the same as in Example 1.
[0089] The results showed that when the headspace equilibrium temperature was set to 60℃, the chromatographic peak area of N,N-dimethylacetamide was approximately 1000. Under this temperature condition, the detection signal was relatively weak, making it difficult to accurately capture minute changes in the N,N-dimethylacetamide content, thus limiting the sensitivity and accuracy of the detection. However, when the headspace equilibrium temperature was increased to 100℃, the experimental results changed; the chromatographic peak area of N,N-dimethylacetamide increased to approximately 2200, a significant increase compared to 60℃. This change directly reflects a significant improvement in detection sensitivity, enabling more accurate determination of the N,N-dimethylacetamide content.
[0090] Comparative Example 3:
[0091] The reference solution 1 prepared in Example 1 was detected by gas chromatography. Except for the different split ratio, the specific gas chromatography conditions were the same as in Example 1.
[0092] The results showed that the peak area response of chloroform was approximately 2000 at a split ratio of 1:2, while it reached 4000 when the split ratio was 1:1. This indicates that the split ratio has a significant impact on the peak area response of chloroform; a smaller split ratio (i.e., 1:1) allows chloroform to achieve a higher peak area response, possibly because a smaller split ratio results in a relatively larger total amount entering the detector, thus generating a stronger signal.
[0093] Example 2: System Applicability
[0094] System suitability: The reference solution 1 with an ethanol concentration of approximately 260.0000 μg / mL, an acetic acid concentration of approximately 260.0000 μg / mL, an N,N-dimethylacetamide concentration of approximately 58.0000 μg / mL, and a benzene concentration of approximately 2.0000 μg / mL, and the reference solution 2 with a trichloromethane concentration of approximately 3.2000 μg / mL, prepared in Example 1, were detected by gas chromatography. The specific gas chromatography conditions were the same as in Example 1, and the peak areas RSD of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and trichloromethane in the solution were recorded.
[0095] The results are as follows Figure 6 , 7 As shown, the RSD of the peak area of ethanol in reference solution 1 was 1.6%, the RSD of the peak area of acetic acid was 1.7%, the RSD of the peak area of N,N-dimethylacetamide was 3.9%, and the RSD of the peak area of benzene was 5.5%. The RSD of the peak area of chloroform in reference solution 2 was 3.9%, all less than 10%. This indicates that the system suitability of this disclosure complies with the requirements.
[0096] Example 3: Limit of Quantification
[0097] Limit of quantitation: Reference solution 1 with an ethanol concentration of approximately 260.0000 μg / mL, an acetic acid concentration of approximately 260.0000 μg / mL, an N,N-dimethylacetamide concentration of approximately 58.0000 μg / mL, and a benzene concentration of approximately 2.0000 μg / mL, and reference solution 2 with a chloroform concentration of approximately 3.2000 μg / mL, prepared in Example 1, were quantitatively diluted stepwise with diluent, and then detected by gas chromatography. The specific gas chromatography conditions were the same as in Example 1, with a signal-to-noise ratio of not less than 10:1. The limit of quantitation was obtained, and the results are shown in Table 1.
[0098] Table 1
[0099]
[0100]
[0101] As shown in Table 1, in the limit of quantitation solution, the S / N ratios of the chromatographic peaks for ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform are all greater than 10; the RSDs of the retention times for ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform are all ≤2.0%; and the RSDs of the peak areas for ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform are all ≤10%. This indicates that the limit of quantitation of this disclosure complies with the regulations.
[0102] Example 4: Detection Limit
[0103] The reference solution 1, with an ethanol concentration of approximately 260.0000 μg / mL, an acetic acid concentration of approximately 260.0000 μg / mL, an N,N-dimethylacetamide concentration of approximately 58.0000 μg / mL, and a benzene concentration of approximately 2.0000 μg / mL, and the reference solution 2, with a chloroform concentration of approximately 3.2000 μg / mL, prepared in Example 1, were diluted to suitable concentrations and used as detection limit solutions. Detection was performed using gas chromatography under the same conditions as in Example 1, with a signal-to-noise ratio of not less than 3. The detection limit was obtained, and the results are shown in Table 2.
[0104] Table 2
[0105]
[0106]
[0107] As shown in Table 2, the S / N ratios of the chromatographic peaks for ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform in the solution at the detection limit are all greater than 3. This indicates that the detection limits of this disclosure comply with the regulations.
[0108] Example 5: Linear Relationship
[0109] Prepare reference solution 1 and reference solution 2 according to Example 1. According to Table 3, accurately transfer appropriate amounts of the stock solutions of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform into suitable brown volumetric flasks, dilute to the mark with diluent, and mix well. Accurately measure 2.0 mL of the above solution, place it in a 20 mL headspace vial, and seal to obtain linear solution 1.
[0110] Table 3
[0111]
[0112] According to Table 4, accurately transfer an appropriate amount of chloroform reference stock solution into a suitable brown volumetric flask, dilute to the mark with diluent, and shake well. Accurately measure 2.0 mL of the above solution, place it in a 20 mL headspace vial, seal, and prepare linear solution 4.
[0113] Table 4
[0114]
[0115]
[0116] Gas chromatography was used for detection, and the GC conditions were the same as in Example 1. Linear curves were plotted with the concentration of each component as the X-axis and the response as the Y-axis. The correlation coefficient R, slope, and linear equation were calculated. The results are shown in Table 5, and the linearity graph is shown below. Figures 8-12 .
[0117] Table 5
[0118]
[0119]
[0120] As shown in Table 5, for ethanol within the range of 78.9300 μg / mL to 526.2000 μg / mL (equivalent to 30% to 200% of the limit concentration), the linear equation is y = 5904.6x - 39338, with a correlation coefficient of 0.999 (≥0.990), indicating good linearity. For acetic acid within the range of 78.9600 μg / mL to 526.4000 μg / mL (equivalent to 30% to 200% of the limit concentration), the linear equation is y = 90.904x - 6632.7, with a correlation coefficient of 0.9985 (≥0.990), also indicating good linearity. For N,N-dimethylacetamide, the linear equation was y = 39.2x - 327.51 with a correlation coefficient of 0.9992 in the range of 17.4600 μg / mL to 116.4000 μg / mL (equivalent to 30% to 200% of the limit concentration), indicating good linearity. For benzene, the linear equation was y = 39.2x - 327.51 with a correlation coefficient of 0.9992 (≥0.990), indicating good linearity. For chloroform, the linear equation was y = 1810.5x - 131.3 with a correlation coefficient of 0.9903 (≥0.990), indicating good linearity.
[0121] Example 6: Repeatability
[0122] Six parallel preparations of reference solution 1, reference solution 2, and spiked test solution 1 and spiked test solution 2 were prepared according to Example 1. Gas chromatography was used for detection, and the specific conditions of gas chromatography were the same as in Example 1. The results are shown in Table 6.
[0123] Table 6
[0124]
[0125]
[0126] As can be seen from Table 6, the RSD of the peak area of ethanol is 3.9%, the RSD of the peak area of acetic acid is 6.1%, the RSD of the peak area of N,N-dimethylacetamide is 8.3%, the RSD of the peak area of benzene is 8.2%, and the RSD of the peak area of chloroform is 9.1%, all of which are ≤10%, indicating that the reproducibility of this disclosure is good.
[0127] Example 7: Intermediate Precision
[0128] Six parallel solutions of reference solution 1, reference solution 2, repeatability solution 1, repeatability solution 2, intermediate precision solution 1, and intermediate precision solution 2 were prepared, following the method described in Example 1. Repeatability solution 1 and intermediate precision solution 1 were prepared in the same manner as spiked test solution 1 in Example 1, and repeatability solution 2 and intermediate precision solution 2 were prepared in the same manner as spiked test solution 2 in Example 1. Detection was performed using gas chromatography under the same conditions as in Example 1. The results are shown in Table 7.
[0129] Table 7
[0130]
[0131]
[0132]
[0133] As shown in Table 7, the intermediate precision RSDs for the peak areas of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform were 2.6%, 8.0%, 9.5%, and 9.4%, respectively, all ≤10%. Comparing the results with 6 reproducible solutions (a total of 12 solutions), the RSDs for the peak areas of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform were 3.2%, 5.1%, 8.3%, 8.9%, and 8.9%, respectively, all ≤10%. This indicates that the detection method of this disclosure has good intermediate precision.
[0134] Example 8: Accuracy
[0135] Accuracy tests for starting ethanol, acetic acid, and N,N-dimethylacetamide are expressed as recovery rates (%).
[0136] Reference Solution 3: Accurately transfer 10 mL of ethanol reference stock solution, 10 mL of acetic acid reference stock solution, 10 mL of N,N-dimethylacetamide reference stock solution, and 1 mL of benzene reference stock solution into a 50 mL amber volumetric flask. Dilute to the mark with diluent and mix well. (Ethanol concentration: 520.0000 μg / mL, 0.0520%; Acetic acid concentration: 520.0000 μg / mL, 0.0520%; N,N-dimethylacetamide concentration: 116.0000 μg / mL, 0.0116%; Benzene concentration: 4.0000 μg / mL, 0.0004%)
[0137] Reference Solution 4: Accurately transfer 1 mL of chloroform reference stock solution into a 50 mL brown volumetric flask, dilute to the mark with diluent, and mix well. (Chloroform concentration: 6.4000 μg / mL, 0.0006%)
[0138] 50% Recovery Test Solution 1: Accurately weigh approximately 2.0 g of iodofol raw material and place it in a 20 mL headspace vial. Accurately transfer 0.5 mL of reference solution 3 and 1.5 mL of purified water, and seal. Prepare three parallel aliquots. (Ethanol concentration: 130.0000 μg / mL, 0.0130%; Acetic acid concentration: 130.0000 μg / mL, 0.0130%; N,N-dimethylacetamide concentration: 29.0000 μg / mL, 0.0029%; Benzene concentration: 1.0000 μg / mL, 0.0001%)
[0139] 100% Recovery Test Solution 1: Accurately weigh approximately 2.0 g of iodofol raw material and place it in a 20 mL headspace vial. Accurately transfer 1.0 mL of reference solution 3 and 1.0 mL of purified water, and seal. Prepare three parallel aliquots. (Ethanol concentration: 260.0000 μg / mL, 0.0260%; Acetic acid concentration: 260.0000 μg / mL, 0.0260%; N,N-dimethylacetamide concentration: 58.0000 μg / mL, 0.0058%; Benzene concentration: 2.0000 μg / mL, 0.0002%)
[0140] 150% Recovery Test Solution 1: Accurately weigh approximately 2.0 g of iodofol raw material and place it in a 20 mL headspace vial. Accurately transfer 1.5 mL of reference solution 3 and 0.5 mL of purified water, and seal. Prepare three parallel aliquots. (Ethanol concentration: 390.0000 μg / mL, 0.0390%; Acetic acid concentration: 390.0000 μg / mL, 0.0390%; N,N-dimethylacetamide concentration: 87.0000 μg / mL, 0.0087%; Benzene concentration: 3.0000 μg / mL, 0.0003%)
[0141] 50% Recovery Test Solution 2: Accurately weigh approximately 2.0 g of iodofol raw material and place it in a 20 mL headspace vial. Accurately transfer 0.5 mL of reference solution 4 and 1.5 mL of purified water, and seal. Prepare three parallel aliquots. (Chloroform concentration: 1.6000 μg / mL, 0.0002%)
[0142] 100% Recovery Test Solution 2: Accurately weigh approximately 2.0 g of iodofol raw material and place it in a 20 mL headspace vial. Accurately transfer 1.0 mL of reference solution 4 and 1.0 mL of purified water, and seal. Prepare three parallel aliquots. (Chloroform concentration: 3.2000 μg / mL, 0.0003%)
[0143] 150% recovery test solution 2: Accurately weigh approximately 2.0 g of iodofol raw material and place it in a 20 mL headspace vial. Accurately transfer 1.5 mL of reference solution 4 and 0.5 mL of purified water, and seal. Prepare three parallel aliquots. (Chloroform concentration: 4.8000 μg / mL, 0.0005%)
[0144] The detection was performed using gas chromatography, with the specific conditions being the same as in Example 1. The results are shown in Table 8.
[0145] Table 8
[0146]
[0147]
[0148] As shown in Table 8, the ethanol recovery rate was within the range of 104.54% to 119.46%, with an RSD of 4.4% (≤10%), which meets the requirements; the acetic acid recovery rate was within the range of 95.02% to 108.74%, with an RSD of 4.8% (≤10%), which meets the requirements; the N,N-dimethylacetamide recovery rate was within the range of 95.09% to 108.3%, with an RSD of 5.1% (≤10%), which meets the requirements; the benzene recovery rate was within the range of 96.73% to 113.67%, with an RSD of 5.9% (≤10%), which meets the requirements; and the chloroform recovery rate was within the range of 92.05% to 117.74%, with an RSD of 8.9% (≤10%), which meets the requirements. This indicates that the detection method disclosed herein has good accuracy.
[0149] Example 9: Solution Stability
[0150] Stability of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform solutions: Stability solutions 1 and 2, reference solutions 1 and 2 were placed at room temperature for different times and then measured. Stability solutions 1 and 2 were prepared in the same way as spiked test solutions 1 and 2 in Example 1. The RSD of the chromatographic peak areas of ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform solutions was calculated. Gas chromatography was used for detection. The specific conditions for gas chromatography were the same as in Example 1. The results are shown in Table 9.
[0151] Table 9
[0152]
[0153]
[0154] As shown in Table 9, the RSD of the peak area for ethanol is 3.0%, for acetic acid it is 6.2%, for N,N-dimethylacetamide it is 7.9%, for benzene it is 10.0%, and for chloroform it is 7.9%, all ≤10%. This indicates that the solution stability of the detection method disclosed in this paper is good.
[0155] Example 10: Durability
[0156] Spiked test solution 1 and spiked test solution 2 were prepared according to Example 1. Gas chromatography was used for detection. Normal conditions refer to the gas chromatography conditions in Example 1: Condition 1: Initial column temperature 38℃, all others as normal; Condition 2: Initial column temperature 42℃, all others as normal; Condition 3: Detector temperature 245℃, all others as normal; Condition 4: Detector temperature 255℃, all others as normal; Condition 5: Injector temperature 225℃, all others as normal; Condition 6: Injector temperature 235℃, all others as normal. The results are shown in Table 10.
[0157] Table 10
[0158]
[0159]
[0160]
[0161] As shown in Table 10, the RSDs for ethanol content measured at different column temperatures were 5.0%, acetic acid content was 9.5%, N,N-dimethylacetamide content was 5.9%, benzene content was 2.8%, and chloroform content was 6.7%, all ≤10%. The RSDs for ethanol content measured at different detector temperatures were 2.7%, acetic acid content was 7.0%, N,N-dimethylacetamide content was 6.9%, benzene content was 7.3%, and chloroform content was 9.6%, all ≤10%. The RSDs for ethanol content measured at different vaporization chamber temperatures were 2.1%, acetic acid content was 9.1%, N,N-dimethylacetamide content was 7.6%, benzene content was 6.9%, and chloroform content was 5.1%, all ≤10%. This indicates that the detection method of this disclosure has good solution robustness.
[0162] Example 11: Sample Measurement
[0163] Following the detection method for residual solvents ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform in iodofol raw material as described in Example 1, two parallel solutions of a batch of samples were injected for analysis. The content of residual solvents ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform in iodofol raw material was detected using the method described in Example 1. Gas chromatography was used for detection, and the specific conditions for gas chromatography were the same as in Example 1. The results are shown in Table 11.
[0164] Table 11
[0165]
[0166] As can be seen from Table 11, ethanol was detected in both parallel samples of iodofol raw material, while acetic acid, N,N-dimethylacetamide, benzene, and chloroform were not detected.
Claims
1. A method for detecting residual solvents in iodofol, comprising headspace gas chromatography, wherein the residual solvents are ethanol, acetic acid, N,N-dimethylacetamide, benzene, and chloroform; The conditions for the headspace gas chromatography method are as follows: The chromatographic column is an ultra-high inert gas chromatographic column, specifically a DB624UI column, with packing material consisting of 6% cyanopropyl / phenyl and 94% polydimethylsiloxane. The headspace equilibrium temperature is 90~110℃, and the headspace equilibrium time is 20~40 min; The column temperature was programmed, with an initial temperature of 36~44℃, and the temperature was increased to 190~210℃ at a rate of 15~25℃ / min, and held for 5~15min. The injection mode is split injection, with a split ratio of 1:
1.
2. The detection method according to claim 1, wherein the carrier gas used in the headspace gas chromatography is nitrogen or helium; And / or, the flow rate of the carrier gas is 2~4 mL / min.
3. The detection method according to claim 2, wherein the carrier gas is nitrogen.
4. The detection method according to claim 2, wherein the flow rate of the carrier gas is 3 mL / min.
5. The detection method according to claim 1, wherein the initial temperature of the headspace gas chromatography is 40°C, and the temperature is increased to 200°C at a rate of 20°C / min and held for 10min.
6. The detection method according to claim 1, wherein the headspace equilibrium temperature of the headspace gas chromatography is 100°C and the headspace equilibrium time is 30 min.
7. The detection method according to claim 1, wherein the injection port temperature of the headspace gas chromatography is 210~240℃; And / or, the detector for the headspace gas chromatography is a flame ionization detector; And / or, the detector temperature for the headspace gas chromatography is 240~260℃.
8. The detection method according to claim 7, wherein the injection port temperature of the headspace gas chromatography is 220°C.
9. The detection method according to claim 7, wherein the temperature of the detector in the headspace gas chromatography is 250°C.
10. The detection method according to claim 1, wherein the injection volume of the headspace gas chromatography is 0.1~3 μL; And / or, the run time of the headspace gas chromatography is 45 to 60 minutes.
11. The detection method according to claim 10, wherein the injection volume is 1 μL.
12. The detection method according to claim 10, wherein the running time is 52 min.
13. The detection method according to claim 1, wherein the detection method comprises the following steps: (1) Prepare a reference solution containing the residual solvent of claim 1; (2) Prepare the test solution of iodofol; (3) Headspace gas chromatography was used to detect the reference solution and the test solution respectively.
14. The detection method according to claim 13, wherein in step (1), the method for preparing the reference solution containing residual solvent includes: The diluent and residual solvent are mixed to obtain the reference stock solution. The reference stock solution is then diluted 5 to 200 times with the diluent to obtain the reference solution. The diluent is water. And / or, in step (2), the preparation method of the test solution of iodofol includes: mixing iodofol and the reference solution in step (1) to obtain the test solution.
15. The detection method according to claim 1, wherein the detection method satisfies one or more of the following: (1) The resolution of one or more peaks of ethanol, chloroform, acetic acid, benzene and N,N-dimethylacetamide detected by the detection method is greater than 1.5; (2) The peak area RSD of one or more peaks of ethanol, chloroform, acetic acid, benzene and N,N-dimethylacetamide detected by the detection method is less than or equal to 10%; (3) The S / N ratio of one or more peaks of ethanol, chloroform, acetic acid, benzene and N,N-dimethylacetamide detected by the detection method is greater than 3; (4) The S / N ratio of one or more peaks of ethanol, chloroform, acetic acid, benzene and N,N-dimethylacetamide detected by the detection method is greater than 10; (5) The retention time RSD of one or more peaks of ethanol, chloroform, acetic acid, benzene and N,N-dimethylacetamide detected by the detection method is less than or equal to 2.0%.
Citation Information
Patent Citations
Method for detecting tromethamine content
CN112946123A
Detection method of posaconazole residual solvent
CN114184721A
